-
Better Buy: PDL BioPharma, Inc. vs. Johnson & Johnson
Post on 2/28/17
-
Ortho Clinical Diagnostics Awarded Top Honor for Global Excellence in Customer Service
Post on 2/27/17
-
Johnson & Johnson Completes Acquisition of Abbott Medical Optics
Post on 2/27/17
-
Upcoming Events: J&J And NeuroDerm Put New Delivery Routes To The Test
Post on 2/27/17
-
Johnson & Johnson May Already Have Its Remicade Replacement Well in Hand
Post on 2/27/17
-
Better Buy: Eli Lilly and Co vs. GlaxoSmithKline plc
Post on 2/27/17
-
These 3 Big Pharma Stocks Are Ridiculously Cheap
Post on 2/27/17
-
Warren Buffett's Bet On This Bank Quadrupled in Just 6 Years
Post on 2/27/17
-
Is Pfizer's Research Pipeline Truly Undervalued?
Post on 2/24/17
-
Celgene: A 'Fuggedaboutit' Core Biotech Holding
Post on 2/24/17
-
Here's Why Celgene's Latest Drug Is So Exciting
Post on 2/24/17
-
New Jersey Plastic Surgeons Introduce Non-Surgical Facelift Alternative
Post on 2/23/17
-
Governor Christie and other Dignitaries Join Victory Bay Recovery Center for a Ribbon-Cutting
Post on 2/23/17
-
HealthSTAR Communications Expands its Strategic Offerings with Launch of HealthSTAR Fusion Group
Post on 2/22/17
-
Symbiomix Therapeutics Appoints David L. Stern as CEO
Post on 2/22/17
-
Better Buy: Pfizer Inc. vs. Merck & Co. Inc.
Post on 2/22/17
-
AGS Health Named to the 2017 Global Outsourcing 100 List
Post on 2/21/17
-
MetroPlus Health Plan Announces New Member Engagement and Rewards Program
Post on 2/21/17
-
Four Amsterdam Dental Group Specialists Named Philadelphia Magazine’s Top Dentists 2017 – Prosthodontics
Post on 2/21/17
-
Pfizer Near A Technical Breakout
Post on 2/21/17
-
Pfizer Is A Solid Buy In 2017
Post on 2/21/17
-
Could Celgene Have Another Billion-Dollar Blockbuster on Its Hands?
Post on 2/21/17
-
Better Buy: Eli Lilly and Company vs. Johnson & Johnson
Post on 2/21/17
-
Better Buy: Gilead Sciences, Inc. vs. Pfizer Inc.
Post on 2/21/17
-
A Billionaire Recently Bought Pfizer Stock -- and So Did I
Post on 2/21/17
Philadelphia
